Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Karyopharm Therapeutics (KPTI) Tax Rate (2017 - 2025)

Historic Tax Rate for Karyopharm Therapeutics (KPTI) over the last 9 years, with Q4 2025 value amounting to 0.07%.

  • Karyopharm Therapeutics' Tax Rate fell 2900.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.02%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.02% for FY2025, which is 500.0% up from last year.
  • As of Q4 2025, Karyopharm Therapeutics' Tax Rate stood at 0.07%, which was down 2900.0% from 0.1% recorded in Q3 2025.
  • Karyopharm Therapeutics' Tax Rate's 5-year high stood at 0.35% during Q4 2024, with a 5-year trough of 0.39% in Q2 2023.
  • Moreover, its 5-year median value for Tax Rate was 0.17% (2024), whereas its average is 0.14%.
  • As far as peak fluctuations go, Karyopharm Therapeutics' Tax Rate skyrocketed by 6700bps in 2024, and later tumbled by -3900bps in 2025.
  • Karyopharm Therapeutics' Tax Rate (Quarter) stood at 0.23% in 2021, then decreased by -15bps to 0.26% in 2022, then decreased by -17bps to 0.31% in 2023, then soared by 214bps to 0.35% in 2024, then tumbled by -81bps to 0.07% in 2025.
  • Its Tax Rate stands at 0.07% for Q4 2025, versus 0.1% for Q3 2025 and 0.11% for Q2 2025.